Impact dashboard

Early progress against an enormous open-literature challenge.

OpenCause Compute helps turn spare computing power into citation-backed research data from open-access cancer literature. This page tracks both the live beta activity and the long-term scale of Cancer Knowledge Miner.

Long-term corpus estimate

~42,914,036

research sections estimated from 2,665,349 eligible open-access cancer documents.

83

Validated sections processed

0

Consensus-complete sections

3

Active worker nodes

1

Volunteer profiles

Current project

Cancer Knowledge Miner

Building a structured, citation-backed map of findings from open-access cancer literature.

Open-access literature

Progress being made

83

validated literature sections processed by early beta workers.

Each one represents a signed literature packet processed by a worker and accepted by OpenCause structure and provenance validation.

Scale of the challenge

~42,914,036

estimated research sections to process.

At full scale, independent validation may require roughly 128,742,108 worker submissions before consensus and review.

Pipeline status

Early beta is strongest in first-pass processing and structure validation. Consensus grows as independent workers process overlapping sections.

Limited beta

83

Worker submissions received

83

Passed structure validation

83

Awaiting independent consensus

0

Consensus complete

Eligible open-access cancer documents

2,665,349

Estimated research sections

~42,914,036

Validated share of estimated sections

<0.01%

Long-term validation progress

<0.01%

This percentage is intentionally tiny in early beta because the corpus is large. It shows the scale of the open-literature challenge, while the beta metrics above show the working pipeline gaining traction.

OpenCause Compute supports research organization and review. It does not provide medical advice, clinical findings, or accepted scientific conclusions.

Why the numbers matter

Validated sections: worker outputs that passed OpenCause structure, citation, and provenance checks. This is pipeline validation, not scientific acceptance.

Scale: open cancer literature is vast. Millions of estimated sections mean the project is designed for sustained volunteer participation, not a one-off demo.

Consensus: candidate evidence becomes more useful after independent workers process overlapping sections and reviewers can inspect the source context.

Top teams

Team impact will appear after teams are created and begin contributing validated work.